Syndax Pharmaceuticals SNDX

$ 13.12 4.79%

Quarterly report 2024-Q3
added 11-05-2024

Syndax Pharmaceuticals Financial Ratios 2011-2025 | SNDX

Annual Financial Ratios Syndax Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
P/E	-8.2	-10.4	32.6	-13.8	-3.6	-1.9	-3.9	-2.5	-	-	-	-	-
P/S	-	-	5.8	664.7	133.9	91.3	111.8	89.8	-	-	-	-	-
EPS	-3.0	-2.5	0.5	-1.9	-1.8	-2.9	-2.9	-3.2	-1519.3	-453.0	-	-	-
EV (Enterprise Value)	1.48 B	1.51 B	631 M	942 M	210 M	136 M	233 M	111 M	26 K	8.52 M	5.21 M	30.8 M	-
EBITDA per Share	-3.1	-1.95	1.33	-1.73	-1.88	-2.99	-2.95	-2.99	-	-	-	-	-
EV/EBITDA	22.9	-11.6	-3.1	-1.4	-3.2	-2.0	-	-	-	-	-
PEG	0.1	0.11	-0.73	0.41	-0.1	2.72	-0.39	0.06	-	-	-	-	-
P/B	3.1	3.3	2.0	4.0	6.4	2.6	2.3	1.3	-	-	-	-	-
P/CF	-10.7	-11.6	27.9	-14.2	-4.0	-2.0	-5.0	-3.1	-	-	-	-	-
ROE %	-37.78	-31.95	6.10	-29.01	-177.36	-139.43	-58.28	-52.86	-	-	-	-	-
ROA %	-34.16	-30.03	5.54	-24.34	-88.23	-88.11	-44.32	-40.80	-	-	-	-	-
ROCE %	-41.45	-32.41	6.11	-25.35	-127.42	-111.86	-51.04	-44.37	-	-	-	-	-
Current Ratio	10.4	16.7	10.9	6.2	3.4	5.2	8.4	10.5	-	-	-	-	-
DSO	-	-	-	-	27.9	60.9	65.3	91.5	-	-	-	-	-
DIO	-	-	-	-	-	-	-	-	-	-	-	-	-
DPO	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Financial Ratios Syndax Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
EPS	-0.98	-0.8	-0.85	-	-0.73	-0.64	-0.59	-	-0.58	-0.62	-0.63	-	-0.4	-0.44	-0.54	-0.44	-0.46	-0.42	-0.56	-0.44	-0.41	-0.47	-0.53	0.7	0.68	0.74	0.79	-0.8	-0.84	-0.47	-2.85	-0.59	-0.84	-0.47	-2.85	-105.57	-790.85	-440.52	-206.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA per Share	-	-	-	-	-	-	-	-	-0.58	-0.63	-0.62	-	-0.39	-0.43	-0.53	-0.43	-0.45	-0.41	-0.44	-0.45	-0.42	-0.49	-0.55	-0.72	-0.71	-0.77	-0.81	-0.81	-0.68	-0.71	-0.72	-0.61	-0.85	-0.48	-1.92	-56.3	-75.4	-88.2	-74.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ROE %	-67.59	-58.87	-54.35	-34.84	-45.31	-41.54	-40.77	-30.78	-41.15	-41.05	-41.34	-33.20	-41.30	-39.03	-35.12	-29.01	-65.21	-97.71	-138.15	-177.36	-168.57	-160.66	-148.12	-139.43	-122.23	-104.01	-82.42	-58.28	-52.83	-56.15	-53.01	-52.86	-37.92	-17.06	-4.67	9.56	7.47	4.41	1.95	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ROA %	-60.17	-53.23	-49.30	-32.10	-41.94	-38.97	-37.87	-27.89	-36.51	-35.28	-34.75	-27.24	-34.03	-32.21	-29.18	-24.34	-39.58	-52.98	-70.78	-88.23	-88.63	-89.09	-87.52	-88.11	-79.60	-69.94	-57.98	-44.32	-40.32	-43.05	-40.77	-40.80	-36.73	-31.60	-30.84	-26.83	-20.97	-12.37	-5.46	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ROCE %	-73.33	-64.54	-59.84	-38.59	-48.96	-43.67	-41.34	-29.83	-39.33	-38.46	-37.77	-29.50	-36.55	-34.10	-30.64	-25.35	-49.76	-71.83	-99.98	-127.42	-124.46	-121.65	-115.54	-111.86	-99.41	-85.83	-69.30	-51.04	-46.28	-49.00	-46.35	-44.37	-31.07	-13.12	-2.00	8.76	6.77	4.26	1.89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.2	11.2	10.6	10.4	10.0	13.8	18.9	16.7	16.7	9.1	8.9	10.9	5.9	5.4	5.4	6.2	6.2	6.2	6.2	2.0	2.0	2.0	2.0	2.7	2.7	2.7	2.7	4.2	4.2	4.2	4.2	4.4	4.4	4.4	4.4	3.9	3.9	3.9	3.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DSO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DIO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DPO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency